1,552
Participants
Start Date
January 29, 2023
Primary Completion Date
March 14, 2024
Study Completion Date
March 14, 2024
rhPro-UK
35 mg, administered intravenously with a bolus of 15 mg within 3 minutes and the remainder by continuous infusion within 30 minutes
rt-PA
0.9 mg/kg (maximum 90 mg), with 10% administered intravenously as a bolus, followed by 90% infusion within 1 hour
Xuancheng People's Hospital, Xuancheng
Beijing Tiantan Hospital, Capital Medical University, Beijing
Xuanwu Hospital, Capital Medical University, Beijing
Huizhou First Hospital, Guangdong
Yuebei People's Hospital, Shaoguan
Handan Central Hospital, Handan
Hengshui People's Hospital (Harrison International Peace Hospital), Hengshui
Hebei General Hospital, Shijiazhuang
The First Hospital of Hebei Medical University, Shijiazhuang
The Second Hospital of Hebei Medical University, Shijiazhuang
Xingtai People's Hospital, Xingtai
The First Affiliated Hospital of Hebei North University, Zhangjiakou
Daqing Oilfield General Hospital, Daqing
Daqing People's Hospital, Daqing
Anyang People's Hospital, Anyang
Luoyang Central Hospital, Luoyang
First Affiliated Hospital of Nanyang Medical College, Nanyang
Nanshi Hospital of Nanyang, Nanyang
Nanyang Second General Hospital, Nanyang
General Hospital of Pingmei Shenma Medical Group, Pingdingshan
Xinxiang Central Hospital, Xinxiang
Zhumadian Central Hospital, Zhumadian
Tongji Hospital affiliated to Huazhong University of Science and Technology, Wuhan
Wuhan Fourth Hospital, Wuhan
Xiangyang Central Hospital, Xiangyang
Baogang Hospital of Inner Mongolia, Baotou
Baotou Central Hospital, Baotou
The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science & Technology, Baotou
Keshiketeng Hospital of Traditional Chinese Medicine and Mongolian Medicine, Chifeng
The Affiliated Hospital of Chifeng University, Chifeng
Affiliated Hospital of Inner Mongolia Medical University, Hohhot
The Affiliated Hospital of Nanjing University Medical School, Nanjing
General Hospital of Xuzhou Coal Mining Group, Xuzhou
The Affiliated Hospital of Xuzhou Medical University, Xuzhou
Xuzhou Central Hospital, Xuzhou
Pingxiang People's Hospital, Pingxiang
Jilin Guowen Hospital, Changchun
The First Hospital of Jilin University, Changchun
The Second Hospital of Jilin University, Changchun
Meihekou Central Hospital, Meihekou
Jilin Neuropsychiatric Hospital, Siping
Tonghua Central Hospital, Tonghua
Ansteel Group General Hospital, Anshan
Benxi Central Hospital, Benxi
Beipiao Central Hospital, Chaoyang
Dalian Municipal Central Hospital, Dalian
Fukuang General Hospital of Liaoning Health Industry Group, Fushun
Fuxinkuang General Hospital of Liaoning Health Industry Group, Fuxin
The First Affiliated Hospital of Jinzhou Medical University, Jinzhou
Central Hospital Affiliated to Shenyang Medical College, Shenyang
The First People's Hospital of Shenyang, Shenyang
The People's Hospital of Liaoning Province, Shenyang
The PLA General Hospital of Northern Theater Command, Shenyang
Xianyang Hospital Of Yan'an University, Xianyang
Dezhou People's Hospital, Dezhou
Tengzhou Central People's Hospital, Dezhou
Shengli Oilfield Central Hospital, Dongying
Jinan City People's Hospital, Jinan
Liaocheng People's Hospital, Liaocheng
Linyi People's Hospital, Linyi
Tai'an Central Hospital, Tai’an
First People's Hospital of Tancheng, Tancheng
Yantai Yuhuangding Hospital, Yantai
Huashan Hospital, Fudan University, Shanghai
Sinopharm Tongmei General Hospital, Datong
Linfen Central Hospital, Linfen
Linfen People's Hospital, Linfen
West China Hospital of Sichuan University, Chengdu
Mianyang Central Hospital, Mianyang
Tianjin Huanhu Hospital, Tianjin
Taizhou First People's Hospital, Taizhou
Zhejiang Taizhou Hospital, Taizhou
Tasly Biopharmaceuticals Co., Ltd.
INDUSTRY